Legal Representation
Attorney
MARY ANTHONY MERCHANT
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 30, 2000 | ABN4 | O | ABANDONMENT - AFTER INTER PARTES DECISION | Loading... |
| Mar 31, 2000 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Mar 30, 2000 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Mar 31, 2000 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Mar 31, 2000 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Mar 30, 2000 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Feb 23, 1999 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Oct 14, 1998 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Sep 22, 1998 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 21, 1998 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jul 14, 1998 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 13, 1998 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 9, 1997 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Sep 23, 1997 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 22, 1997 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations, namely, angiogenesis inhibitor protein compositions for the treatment of diseases and biological processes that are mediated by angiogenesis, namely, cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005